⏳ Fetching live dividend data...
Home › Calculator › APLT Dividend Calculator 2026
Applied Therapeutics, Inc. · NASDAQ
Price: $0.10 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in APLT → $125898477972.10M in 10 years · $9,977,688,854,977,092.00/month
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for cardiovascular conditions, galactosemia, and various diabetes-related complications. The company's primary drug candidate, AT-007, has successfully concluded Phase 1/2 studies for galactosemia in healthy adult volunteers and is presently in a pediatric clinical study for the same indication in children. Additionally, AT-007 is being investigated for its potential to address sorbitol dehydrogenase deficiency and phosphomannomutase enzyme-CDG. Another key compound, AT-001, is currently undergoing pivotal Phase III clinical trials. This therapy is being evaluated for its efficacy in treating both diabetic cardiomyopathy and diabetic peripheral neuropathy. Beyond its clinical pipeline, the company also maintains an early-stage preclinical portfolio. This includes AT-003, which is being developed for diabetic retinopathy, and AT-104. AT-104 is a PI3K inhibitor specifically designed to target T-Cell Acute Lymphoblastic Leukemia, a rare form of blood cancer. Applied Therapeutics, Inc. was established in 2016 and operates from its headquarters in New York City.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open APLT position with:
Real after-tax yield depends on where you live and how you hold APLT.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 1941.75% | 1938.95% | $194,175 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1650.49% | 1647.69% | $165,049 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1553.40% | 1550.60% | $155,340 / yr |
| 🇬🇧 UK ISA | 0% | 1941.75% | 1938.95% | $194,175 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1771.85% | 1769.05% | $177,185 / yr |
| 🇨🇦 TFSA | 0% | 1941.75% | 1938.95% | $194,175 / yr |
| 🇨🇦 CA Taxable | 25% | 1456.31% | 1453.51% | $145,631 / yr |
| 🇦🇺 Super (pension) | 15% | 1650.49% | 1647.69% | $165,049 / yr |
| 🇦🇺 AU Taxable | 30% | 1359.22% | 1356.42% | $135,923 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1429.61% | 1426.81% | $142,961 / yr |
| 🇫🇷 FR Taxable | 30% | 1359.22% | 1356.42% | $135,923 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
APLT pays quarterly — 4 times per year. Next ex-div: TBD.
How APLT compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for APLT sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| D-Return | 2026-02-03 | 22,500 | $0.09 | $2.0K | ||
| D-Return | 2026-02-03 | 200,000 | $0.40 | $79.0K | ||
| U-Tender | 2026-02-03 | 42,500 | $0.09 | $3.7K | ||
| D-Return | 2026-02-03 | 16,500 | $1.05 | $17.3K | ||
| A-Award | 2025-12-19 | 312,500 | — | — | ||
| D-Return | 2026-02-03 | 862,500 | $0.09 | $75.9K | ||
| U-Tender | 2026-02-03 | 5,753 | — | — | ||
| A-Award | 2025-12-19 | 437,500 | — | — | ||
| D-Return | 2026-02-03 | 1,000,000 | $0.09 | $88.0K | ||
| U-Tender | 2026-02-03 | 57,111 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the APLT dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →